Epigallocatechin-3-gallate was shown to have a vital role in the inhibition of melanoma cell growth at physiological doses and reduced NF-κB activity was linked with decreased IL-1β secretion from melanoma cells [132]. The gene discussed is IL1B; the disease is melanoma.